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Background/aim: Postoperative pain control constitutes a major problem and studies have focused on reducing opioid requirements
using regional techniques. We aimed to investigate the efficacy of wound infiltration with lornoxicam on postoperative pain control
following thyroidectomy.
Materials and methods: In this prospective, randomized-controlled study, 80 patients scheduled for thyroidectomy were randomly
assigned to 2 groups. After the thyroidectomy was performed, patients in group I underwent wound infiltration with 4 mg of lornoxicam
and patients in group II received the same amount of saline. Rescue analgesia was provided with additional doses of lornoxicam delivered
by an on-demand patient-controlled analgesia device. Total analgesic consumption during the postoperative 24 h, and pain intensities
assessed using a visual analog scale score at 0, 2, 4, 8, 12 and 24 h postoperatively were recorded.
Results: Pain scores during the postoperative 24 h were slightly lower in group I than in group II, but the difference was not significant
(P > 0.05). The mean analgesic consumption was 8.87 ± 1.87 mg and 10.33 ± 1.25 mg in groups I and II, respectively (P > 0.05).
Conclusion: Wound infiltration with lornoxicam neither improved postoperative pain control nor decreased total analgesic consumption.
Key words: Wound infiltration, lornoxicam, postoperative pain, thyroidectomy

1. Introduction
Thyroidectomy is the most frequently performed procedure
in endocrine surgery all around the world. With the
introduction of new energy devices and the development
of minimally invasive techniques in the era of thyroid
surgery, postoperative hemorrhage and hypocalcemia
have been minimized and the surgical procedure has been
performed increasingly as an ambulatory surgery during
the last decade (1,2). Today, postoperative pain constitutes
one of the major obstacles to day care surgery.
Postoperative pain related to thyroid surgery is estimated
to be of moderate to severe intensity, and most patients
require narcotic analgesics for pain control (3). Effective
postoperative pain management can provide patients comfort;
moreover, it can shorten functional recovery time and enable
patients to return to daily activities and work sooner (4).
Traditional pain management achieved this objective by using
large amounts of opioid analgesics with many undesired side
effects. The role of connective tissue trauma and inflammation
as potent factors for the development of postoperative
pain are well understood. In addition, nonsteroidal anti* Correspondence: zkilbas@yahoo.com
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inflammatory drugs (NSAIDs) are known to act by inhibiting
prostaglandin synthesis, both in the central nervous system
and in the damaged soft tissue region. Thus, systemic or local
administration of NSAIDs may help to decrease the intensity
of postoperative pain and the level of analgesic consumption
by attenuating the inflammation and edema. As it is
understood that combination therapies targeting different
sites of the pain pathway have better results, recent studies
have focused on wound infiltration analgesia by using new
agents to reduce opioid use and its side effects.
Lornoxicam, one of the oxicam class of NSAIDs, is a
potent analgesic with anti-inflammatory properties in a
range of painful conditions, including postoperative pain
(5,6). The peroral and parenteral forms of lornoxicam
have been used to treat moderately acute postoperative
pain (5,7). In addition, local administration of lornoxicam
combined with a local anesthetic has been found safe and
effective in clinical trials (8,9). However, the efficacy of
wound infiltration analgesia with lornoxicam alone for
postoperative pain management after thyroid surgery has
not been studied yet.

KILBAŞ et al. / Turk J Med Sci
The aim of this double-blind, prospective randomized
and placebo-controlled study was to investigate the
analgesic efficacy of wound infiltration with lornoxicam
in patients undergoing thyroidectomy based on their
pain intensity scores and 24 h of postoperative analgesic
consumption.
2. Material and methods
After institutional approval was obtained from the Ethics
Committee of the Gülhane School of Medicine, Ankara,
Turkey, and written informed consent, 80 adult patients
aged 20–65, scheduled for partial or total thyroidectomy,
and with American Society of Anesthesiologists (ASA)
classification I or II were enrolled in the study. The study
was carried out between 2007 and 2009, in the Gülhane
School of Medicine, Department of General Surgery,
Ankara, Turkey.
Exclusion criteria included a known intolerance or
allergy to any drugs used in the study, cardiovascular or
respiratory disease, renal or liver failure, coagulopathy,
alcohol addiction, and opioid addiction. In addition,
patients who did not want to participate in the study, had
undergone previous thyroid surgery, or had undergone
thyroid resection in combination with neck dissection
were excluded.
In this prospective randomized, placebo-controlled
study, the 80 patients were randomly divided into 2 groups
of 40 patients in each: group I, in which wound infiltration
with 4 mg lornoxicam was done, and group II, a control
group in which wound infiltration was done with the same
amount of physiological saline.
The severity of pain was assessed using a visual analog
scale (VAS) and patients were informed about the VAS
ratings (0 = no pain, 100 = the worst possible pain) and
about the use of the patient-controlled analgesia (PCA)
pump. Patients were asked to evaluate their postoperative
pain using the VAS at 0, 2, 4, 8, 12, and 24 h , both at rest and
at movement of the neck in two directions (up–down and
left–right). Systolic blood pressure (SBP), diastolic blood
pressure (DBP), peripheral oxygen saturation (SpO2),
heart rate (HR), and respiratory rate (RR) of patients
were recorded before and 0, 2, 4, 8, 12, and 24 h after the
operation by nurses who were blinded to the study group.
Sedation was evaluated using a five-point numerical scale,
with 0 = alert and 4 = deep sleep.
2.1. Anesthesia and surgical procedure
A standardized anesthesia protocol was used for all our
patients. Preinduction was carried out with intravenous
midazolam (1–1.5 mg) and fentanyl (2 µg/kg), and then
induction was performed with intravenous propofol
(1.5–2 mg/kg). Tracheal intubation was facilitated with
atracurium (0.5 mg/kg) and patients were maintained
with 1.5%–2% sevoflurane in a mixture of 66% nitrous

oxide and 34% oxygen. No opioids were administered
intraoperatively. The thyroidectomies were performed
by three different surgical teams using a standardized
technique with elevation of the subplatysmal flaps,
retraction of the strap muscles, and the routine use of
suction drains in all patients. Suction drains were taken
off at the first postoperative day and no hematomas or
seromas were observed in any patients.
2.2. Infiltration analgesia
At the completion of each thyroidectomy and before
skin closure, wound infiltration was performed by the
surgeons, who were blinded to the applied medications.
An anesthetist prepared and labeled the study drugs. The
patients in group I (lornoxicam group) underwent wound
infiltration with 4 mg of lornoxicam (Xefo; Nycomed
Pharma AS, Roskilde, Denmark) diluted with 10 cc of
saline and the infiltration was applied into the front group
cervical muscles and subcutaneous tissue in both flaps (top
and bottom) so as to be 2.5 cc for each side. The patients
in group II (saline group) were administered the same
amount (10 mL) of saline in the same manner.
After tracheal extubation, patients in both groups
were transferred to the postanesthesia recovery unit and
postoperative analgesia was maintained by intravenous
infusion of lornoxicam (prepared to 12 mg/100 mL) via a
PCA pump. The PCA pump was programmed as follows:
bolus dose of 4 mg, continuous infusion of 0.12 mg/h,
demand dose of 0.2 mg, and lock-out interval of 30 min.
Further PCA doses of lornoxicam were delivered as 0.2 mg
doses on patient demand.
Total lornoxicam consumption during the postoperative
24 h, VAS scores, and hemodynamic parameters were
recorded at specific time intervals. Any side effects related
to the agents used in the study and postoperative nausea
and vomiting were recorded and treated as necessary.
2.3. Outcomes
The primary outcome variable of our study was total
analgesic consumption (lornoxicam mg/kg) for the
24-h-long postoperative period. The secondary outcome
variables were the VAS scores at specific time intervals.
2.4. Statistical analysis
Calculation of sample size was performed using power
analysis and sample size calculation software. A sample
size of 40 patients per group was needed to demonstrate
a significant difference with a power of 80% and an
a-coefficient of 0.05. The results are presented as count,
percent (%), and mean values with their standard
deviations (SD). The Mann–Whitney U test was used to
assess VAS scores, consumed dose of lornoxicam, and
hemodynamic parameters. Fisher’s exact test was used for
the evaluation of sex and ASA scores. A P value < 0.05 was
considered statistically significant.
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3. Results
All 80 patients, randomized by using sealed envelopes,
completed the study (Table 1). The 2 groups did not differ
in terms of distribution of age, sex, weight, ASA score, or
duration of surgery (Table 2). There were no statistically
significant differences in sedation or the hemodynamic
parameters including SBP, DBP, RR, HR, and SpO2 between
the 2 groups during the postoperative 24 h. Postoperative
nausea and vomiting was observed in 3 patients in group I
and in 2 patients in group II.

3.1. Postoperative analgesic consumption
Postoperative analgesic consumption (mg) over 24 h was
the total amount of lornoxicam administered with the
PCA pump to attain a VAS of <30. In group I, the mean
24 h consumption of lornoxicam was 8.87 ± 1.87 mg and it
was 10.33 ± 1.25 mg for group II (P = 0.416). There was no
statistically significant difference in terms of postoperative
analgesic consumption between the groups (Table 3).

Table 1. Flow diagram of the study.
Flow Diagram

Enrollment

Assessed for eligibility (n=85 )
Excluded (n= 5)
Not meeting inclusion criteria (n=3)
Declined to participate (n= 2)
Other reasons (n= 0)

Randomized (n=80)

Allocation
Allocated to intervention (n=40)
Recei ved allocated intervention (n=40)

Allocated to intervention (n=40)
Received allocated intervention (n= 40)

Follow-Up.
Lost to follow-up (give reasons) (n= 0)

Lost to follow-up (give reasons) (n= 0)

Discontinued intervention (give reasons) (n=0)

Discontinued intervention (give reasons) (n=0)

Analysis
Analyzed (n= 40)
Excluded from analysis (give reasons) (n= 0)

Analyzed (n= 40)
Excluded from analysis (give reasons) (n= 0)

Table 2. Demographic characteristics and surgical data of patients.
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Group I
(n = 40)

Group II
(n = 40)

P

Age

40.35 ± 11.58

44.14 ± 12.40

0.307

Weight (kg)

68.30 ± 10.61

73.52 ± 11.0

0.92

Operation time (min)

128.04 ± 30.25

132.39 ± 23.51

0.634

Sex (M/F)

9/31

10/30

0.123

ASA (I/II)

29/11

31/9

0.346
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Table 3. Comparison of analgesic requirements during postoperative 24 h.
Group II

P

8.87 ± 1.87

10.33 ± 1.25

0.416

3.2. Postoperative visual analog scores
Although postoperative pain scores (both at rest and at
neck movement) were lower with lornoxicam compared
with the placebo at the specific time intervals (Figures
1 and 2), the difference between the groups at all time
intervals was not statistically significant (P > 0.05). In
addition, the average of the VAS scores at rest and at neck
movement was not statistically different between the
groups (Figure 3).
4. Discussion
This prospective, randomized, placebo-controlled
study demonstrated that wound infiltration with
lornoxicam alone does not reduce postoperative analgesic
consumption following thyroidectomy. On the other hand,

VAS (0-100)
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0
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Group II

0
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4
8
12
postoperative period (hours)

24

Figure 1. Comparison of the postoperative VAS pain scores at
rest. Values are presented as mean ± standard deviation.
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Figure 2. Comparison of the postoperative VAS pain scores
at neck movement. Values are presented as mean ± standard
deviation.
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0

VAS (0-100)

Total Lornoxicam (mg) consumption

Group I

Group I
Group II

At rest

At neck movement

Figure 3. Average of VAS pain scores at rest and at neck
movement in two directions (up–down and left–right).

as a secondary outcome of the study, the results showed
that postoperative pain control after thyroid surgery can
be achieved with lornoxicam administered via PCA.
Postoperative pain is an undesirable condition that can
delay functional recovery and cause prolongation in length
of hospital stay. An effective management of postoperative
pain relieves suffering and leads to earlier mobilization,
reduced hospital costs, and increased patient satisfaction
(10–12).
Thyroid surgery with a mean postoperative VAS score
of 69 is considered to be moderately painful (13,14). Recent
reports suggest that patients experience a significant
amount of pain, especially in the early postoperative hours,
despite modern and less invasive surgical techniques (13).
In the development of the pain after thyroid surgery,
inflammation from tissue trauma (due to dissection
and retraction of the deep and superficial layers) and
hyperextension of the neck during surgery play a major
role (15).
Since day care surgery is an option for thyroid surgery
and it is being increasingly performed, postoperative pain
control has gained critical importance. Opioids are the
traditional first-line analgesics most commonly used for
postoperative pain control. However, they have a wide
range of side effects including respiratory depression,
sedation, nausea, vomiting, and a delay in return of
gastrointestinal function (16).
The current concept in the management of
postoperative pain is minimizing the dose of opioids to
reduce side effects while still providing adequate analgesia.
This goal may be accomplished with a multimodal
approach and infiltration analgesia (17).
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Local anesthetic or NSAID infiltration as a part of
multimodal analgesia is performed to decrease the pain
after surgery. Incision-site local anesthetic infiltration
has been found to be effective for the management of
postoperative pain, especially in radical prostatectomy
and laparoscopic cholecystectomy (18,19). However, our
literature search did not reveal any study related to the effect
of wound infiltration with lornoxicam alone in thyroid
surgery. There are limited trials regarding the effects of
infiltration analgesia and the results are controversial.
Gozal et al. demonstrated the pain-reducing effect
of local anesthetic (bupivacaine) infiltration in thyroid
surgery and they found that the 24-h morphine requirement
and the mean pain scores were significantly less in the
treatment group (20). Similarly, wound infiltration with
local anesthetics and bilateral superficial and deep cervical
plexus block were reported to reduce postoperative pain
and opioid requirements after thyroid surgery (15,21–23).
Karamanlioglu et al. demonstrated that wound infiltration
with the combination of lornoxicam and ropivacain
effectively reduced postoperative pain during the first 12
h (24). Furthermore, they found that time to first analgesic
was significantly longer in the treatment group than in the
control group.
On the other hand, there also exist some other studies
reporting opposite results regarding the effects of wound
infiltration (14). A meta-analysis consisting of randomized
trials reported that wound infiltration significantly
decreased postoperative analgesic consumption, and in
addition, it increased time to first analgesic requirement
(25). However, in terms of postoperative pain scores, they
found no significant differences in patients who had wound
infiltration with local anesthetic. Some randomized trials
have demonstrated that local anesthetic injection around
incision sites can reduce postoperative somatic pain, but
this is not the case for visceral pain (26,27).
Since we did not use any opioids for postoperative pain
management, our study demonstrated that postoperative
pain control can be accomplished with the use of NSAIDs
alone, and thus the side effects of opioids or narcotics
can be avoided. Secondly, lornoxicam can be safely used
both as an infusional analgesic with a PCA device or as an

infiltration analgesia agent. The use of lornoxicam with a
PCA can contribute to postoperative pain treatment with
low dose analgesics and increase patient comfort.
In the management of mild to moderate postoperative
pain, NSAIDs have been studied as a single agent and the
results are satisfactory. In a randomized controlled clinical
trial, single doses of lornoxicam (4 and 8 mg intravenous)
were compared to those of tramadol (50 mg) in patients
undergoing hysterectomy and lornoxicam was found to be
more effective than tramadol in controlling postoperative
pain as well as being better tolerated (28).
There have been an increasing number of studies
conducted to investigate the effect of local infiltration
with NSAIDs in postoperative pain. The results of these
studies demonstrated that there is evidence for a clinically
relevant peripheral analgesic effect of wound infiltration
with NSAIDs (29,30).
Our study presents some limitations. First of all, three
different surgical teams were involved in the study, but
they operated with the same standardized technique and
the durations of the surgical procedures were similar.
In addition, we used lornoxicam both as an infiltrating
analgesic and as a rescue analgesic; if we had used a
different agent as the rescue analgesic, the criteria of
postoperative analgesic consumption would be a more
objective parameter. This decision was made because
we wanted to investigate whether lornoxicam alone
could be an alternative to opioids for the management of
postoperative pain.
An allergic reaction to the agents used, a prolongation
in wound healing, and a risk of wound infection are the
most common concerns with the infiltration analgesia
technique, but we did not observe any signs of wound
infection or allergic reaction in any of the patients.
In conclusion, wound infiltration with lornoxicam
alone did not significantly reduce postoperative pain
intensities or analgesic consumption when compared
with saline in patients undergoing thyroid surgery. On the
other hand, our results suggest that lornoxicam can be an
alternative to opioids when administered by PCA for the
treatment of moderate to severe postoperative pain.
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